Artwork

İçerik The Business Magazine tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan The Business Magazine veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Player FM - Podcast Uygulaması
Player FM uygulamasıyla çevrimdışı Player FM !

Aurrigo's 160% Surge, Oxford Drug Design Funding, Fossil-Free Fuel at National Oceanography Centre

2:12
 
Paylaş
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on December 06, 2024 11:10 (1M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 442961240 series 3522529
İçerik The Business Magazine tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan The Business Magazine veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

These are the top stories making the headlines across The Business Magazine website today:

Aurrigo International sees strong growth in autonomous division in first half

Coventry-based Aurrigo International plc reported a significant first-half growth in its autonomous ground handling technology division, achieving £800,000 in revenue—a 160% increase— and projecting annual sales to reach £3 million.

Full story here: https://thebusinessmagazine.co.uk/companies/aurrigo-international-sees-strong-growth-in-autonomous-division-in-first-half/

Oxford Drug Design set to help advance new treatments for CF lung infections

Oxford Drug Design has received £466,000 from the Cystic Fibrosis Antimicrobial Resistance Syndicate’s £3 million Collaborative Discovery Programme, funded by LifeArc, to develop new treatments targeting bacterial infections in Cystic Fibrosis patients using AI technology.

Full story here: https://thebusinessmagazine.co.uk/companies/oxford-drug-design-set-to-help-advance-new-treatments-for-cf-lung-infections/

Southampton’s National Oceanography Centre trials low-carbon fuel

On World Maritime Day, Southampton’s National Oceanography Centre marked the occasion by successfully trialing fossil-free marine diesel made from hydrotreated vegetable oil (HVO) on two of its Royal Research Ships, James Cook and Discovery.

Full story here: https://thebusinessmagazine.co.uk/esg/southamptons-national-oceanography-centre-trials-low-carbon-fuel/

  continue reading

257 bölüm

Artwork
iconPaylaş
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on December 06, 2024 11:10 (1M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 442961240 series 3522529
İçerik The Business Magazine tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan The Business Magazine veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

These are the top stories making the headlines across The Business Magazine website today:

Aurrigo International sees strong growth in autonomous division in first half

Coventry-based Aurrigo International plc reported a significant first-half growth in its autonomous ground handling technology division, achieving £800,000 in revenue—a 160% increase— and projecting annual sales to reach £3 million.

Full story here: https://thebusinessmagazine.co.uk/companies/aurrigo-international-sees-strong-growth-in-autonomous-division-in-first-half/

Oxford Drug Design set to help advance new treatments for CF lung infections

Oxford Drug Design has received £466,000 from the Cystic Fibrosis Antimicrobial Resistance Syndicate’s £3 million Collaborative Discovery Programme, funded by LifeArc, to develop new treatments targeting bacterial infections in Cystic Fibrosis patients using AI technology.

Full story here: https://thebusinessmagazine.co.uk/companies/oxford-drug-design-set-to-help-advance-new-treatments-for-cf-lung-infections/

Southampton’s National Oceanography Centre trials low-carbon fuel

On World Maritime Day, Southampton’s National Oceanography Centre marked the occasion by successfully trialing fossil-free marine diesel made from hydrotreated vegetable oil (HVO) on two of its Royal Research Ships, James Cook and Discovery.

Full story here: https://thebusinessmagazine.co.uk/esg/southamptons-national-oceanography-centre-trials-low-carbon-fuel/

  continue reading

257 bölüm

Усі епізоди

×
 
Loading …

Player FM'e Hoş Geldiniz!

Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.

 

Hızlı referans rehberi

Keşfederken bu şovu dinleyin
Çal